|

Belimumab Clinical Trials

4 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Any other treatment, Benlysta

Pipeline

Phase 1: 1Phase 2: 1Phase 4: 2

Top Sponsors

  • Peking Union Medical College Hospital1
  • Northwell Health1
  • Nanjing University School of Medicine1
  • GlaxoSmithKline1

Indications

  • Lupus3
  • Lupus Nephritis (LN)1
  • Lupus Erythematosus1
  • Lupus Erythematosus, Systemic1
  • Sjogren's Syndrome1

Other2 trials

Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Phase 2

Scottsdale, Arizona1 trial

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

GSK Investigational Site

Phase 1

Manhasset, New York1 trial

Trial of Belimumab in Early Lupus

Feinstein Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.